STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
- PMID: 30158673
- DOI: 10.1038/s41388-018-0449-z
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
Abstract
Immunosuppressive myeloid-derived suppressor cells (MDSC) subvert antitumor immunity and limit the efficacy of chimeric antigen receptor T cells (CAR-T). Previously, we reported that the GM-CSF/JAK2/STAT3 axis drives liver-associated MDSC (L-MDSC) proliferation and blockade of this axis rescued antitumor immunity. We extended these findings in our murine liver metastasis (LM) model, by treating tumor-bearing mice with STAT3 inhibitors (STATTIC or BBI608) to further our understanding of how STAT3 drives L-MDSC suppressive function. STAT3 inhibition caused significant reduction of tumor burden as well as L-MDSC frequencies due to decrease in pSTAT3 levels. L-MDSC isolated from STATTIC or BBI608-treated mice had significantly reduced suppressive function. STAT3 inhibition of L-MDSC was associated with enhanced antitumor activity of CAR-T. Further investigation demonstrated activation of apoptotic signaling pathways in L-MDSC following STAT3 inhibition as evidenced by an upregulation of the pro-apoptotic proteins Bax, cleaved caspase-3, and downregulation of the anti-apoptotic protein Bcl-2. Accordingly, there was also a decrease of pro-survival markers, pErk and pAkt, and an increase in pro-death marker, Fas, with activation of downstream JNK and p38 MAPK. These findings represent a previously unrecognized link between STAT3 inhibition and Fas-induced apoptosis of MDSCs. Our findings suggest that inhibiting STAT3 has potential clinical application for enhancing the efficacy of CAR-T cells in LM through modulation of L-MDSC.
Similar articles
-
Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.Cancer Gene Ther. 2016 Jun;23(6):188-98. doi: 10.1038/cgt.2016.19. Epub 2016 May 20. Cancer Gene Ther. 2016. PMID: 27199222
-
Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects.Cancer Lett. 2024 Aug 28;598:217111. doi: 10.1016/j.canlet.2024.217111. Epub 2024 Jul 6. Cancer Lett. 2024. PMID: 38972347
-
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.Cancer Immunol Immunother. 2015 Jul;64(7):817-29. doi: 10.1007/s00262-015-1692-6. Epub 2015 Apr 8. Cancer Immunol Immunother. 2015. PMID: 25850344 Free PMC article.
-
Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.Arch Pharm Res. 2016 Nov;39(11):1597-1608. doi: 10.1007/s12272-016-0822-9. Epub 2016 Aug 29. Arch Pharm Res. 2016. PMID: 27572156 Review.
-
Myeloid cells as a _target for oligonucleotide therapeutics: turning obstacles into opportunities.Cancer Immunol Immunother. 2017 Aug;66(8):979-988. doi: 10.1007/s00262-017-1966-2. Epub 2017 Feb 18. Cancer Immunol Immunother. 2017. PMID: 28214929 Free PMC article. Review.
Cited by
-
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress.Pharmaceutics. 2024 Feb 8;16(2):251. doi: 10.3390/pharmaceutics16020251. Pharmaceutics. 2024. PMID: 38399305 Free PMC article. Review.
-
The role of myeloid-derived suppressor cells in gastrointestinal cancer.Cancer Commun (Lond). 2021 Jun;41(6):442-471. doi: 10.1002/cac2.12156. Epub 2021 Mar 27. Cancer Commun (Lond). 2021. PMID: 33773092 Free PMC article. Review.
-
Malat1 regulates PMN-MDSC expansion and immunosuppression through p-STAT3 ubiquitination in sepsis.Int J Biol Sci. 2024 Feb 11;20(4):1529-1546. doi: 10.7150/ijbs.92267. eCollection 2024. Int J Biol Sci. 2024. PMID: 38385073 Free PMC article.
-
IL-6 Promotes the Proliferation and Immunosuppressive Function of Myeloid-Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer.Biomed Res Int. 2021 Apr 23;2021:5535578. doi: 10.1155/2021/5535578. eCollection 2021. Biomed Res Int. 2021. PMID: 33981768 Free PMC article.
-
The Roles of Myeloid-Derived Suppressor Cells in Liver Disease.Biomedicines. 2024 Jan 27;12(2):299. doi: 10.3390/biomedicines12020299. Biomedicines. 2024. PMID: 38397901 Free PMC article. Review.
References
-
- Guha P, Reha J, Katz SC. Immunosuppression in liver tumors: opening the portal to effective immunotherapy. Cancer Gene Ther. 2017;24:114–20. - DOI
-
- Katz SC, Pillarisetty VG, Bleier JI, Kingham TP, Chaudhry UI, Shah AB, et al. Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors. Hepatology. 2005;42:293–300. - DOI
-
- Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, et al. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2013;20:946–55. - DOI
-
- Katz SC, Pillarisetty V, Bamboat ZM, Shia J, Hedvat C, Gonen M, et al. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol. 2009;16:2524–30. - DOI
-
- Turcotte S, Katz SC, Shia J, Jarnagin WR, Kingham TP, Allen PJ, et al. Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. Cancer Immunol Res. 2014;2:530–7. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous